Carrying extra fat tissue causes your body to produce more estrogen than it needs
Gallbladder-related adverse events, including cholelithiasis and cholecystitis, have been reported more frequently in patients receiving semaglutide compared to placebo in clinical trials, with an incidence of approximately two to three percent
Zepbound, another injectable with a dual-action mechanism targeting GLP-1 and GIP receptors, has demonstrated the highest weight loss efficacy among available medications, achieving up to 20.9% body weight loss
Safety, Suitability, and Practical Notes Common adverse effects: GI upset, nausea, constipation
Your Prescription (Upon Eligibility) Receive your prescribed medication with free shipping, delivered right to your doorstep when you need it
You dont have to figure it out alonethis is what we do best: helping you repair, regulate, and come back home to your body